利润表
COHERUS ONCOLOGY, INC.
CHRS
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
- | - | - | - | - | - | - | 0.00 | 1.56 | 190.11 | 30.04 | 31.11 |
|
营业成本
|
13.81 | 117.55 | 158.99 | 70.08 | 57.59 | 37.67 | - | - | - | - | - | - |
|
毛利润
|
-13.81 | -117.55 | -158.99 | -70.08 | -57.59 | -37.67 | - | - | 1.56 | 190.11 | 30.04 | 31.11 |
|
营业费用
|
209.49 | 261.07 | 301.45 | 397.84 | 532.82 | 281.84 | 248.30 | 204.42 | 233.69 | 306.04 | 249.11 | 95.79 |
|
研发费用
|
108.89 | 93.34 | 109.44 | 199.36 | 363.11 | 142.76 | 94.19 | 110.24 | 162.39 | 254.44 | 213.06 | 78.22 |
|
销售、一般及行政费用
|
100.60 | 167.74 | 192.02 | 198.48 | 169.71 | 139.08 | 137.04 | 94.18 | 71.30 | 51.60 | 36.05 | 17.56 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-223.31 | -378.63 | -460.44 | -467.92 | -590.41 | -319.51 | -248.30 | -204.42 | -232.14 | -115.93 | -219.07 | -64.68 |
|
营业外收入
|
-40.18 | -407.13 | -222.17 | -176.17 | -303.31 | -455.21 | -341.08 | - | - | - | - | - |
|
利息收入
|
7.00 | 4.50 | 2.80 | 1.90 | 1.40 | 0.60 | 1.60 | 1.40 | 0.80 | - | - | - |
|
利息支出
|
9.00 | 27.16 | 40.54 | 32.47 | 22.96 | 21.17 | 17.60 | 9.70 | 9.60 | 7.98 | 0.03 | 3.90 |
|
其他营业外收入/支出
|
7.01 | 3.37 | 5.47 | 3.82 | -0.28 | 0.55 | 2.61 | 4.69 | 3.40 | -3.88 | -4.10 | 3.60 |
|
税前利润
|
-183.12 | 28.51 | -238.27 | -291.75 | -287.10 | 135.71 | 92.78 | - | - | - | - | - |
|
所得税费用
|
-351.15 | 0.00 | -0.38 | 0.00 | 0.00 | 3.46 | 2.94 | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | 0.00 | -0.07 | -0.12 | -0.45 | -0.68 | -0.04 |
|
净利润
|
168.02 | 28.51 | -237.89 | -291.75 | -287.10 | 132.24 | 89.83 | -209.34 | -238.17 | -127.34 | -223.26 | -87.13 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-219.38 | -373.35 | -456.65 | -464.22 | -586.91 | -316.61 | -245.00 | -201.18 | -228.74 | -112.94 | -217.20 | -64.01 |
|
基本每股收益
|
1.43 | 0.25 | -2.53 | -3.76 | -3.81 | 1.85 | 1.29 | - | - | - | - | - |
|
稀释每股收益
|
1.43 | 0.25 | -2.53 | -3.76 | -3.81 | 1.62 | 1.23 | - | - | - | - | - |
|
加权平均股数
|
117.14 | 114.55 | 94.16 | 77.63 | 75.45 | 71.41 | 69.68 | - | - | - | 37.13 | 8.52 |
|
稀释加权平均股数
|
117.14 | 114.83 | 94.16 | 77.63 | 75.45 | 83.49 | 73.19 | - | - | - | - | - |
|
综合收益
|
- | - | - | - | - | 132.53 | 89.56 | -208.87 | -238.29 | -127.57 | -223.14 | -87.66 |